A simple mesh could stop a common complication after liver transplants
NCT ID NCT07744230
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study tests whether placing a bio-absorbable mesh during liver transplant surgery can prevent incisional hernias—bulges that can form at the surgical cut—in patients at high risk. About 100 adults who have at least three risk factors (like older age, obesity, or diabetes) will receive the mesh as part of their transplant procedure. Researchers will track how many develop a hernia over two years, along with any surgical complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bio-absorbable mesh (PHASIX) placed under the skin during surgery
- What this could lead to
- If effective, this approach could reduce the need for hernia repair surgery after liver transplants, improving recovery and quality of life.
- What could go wrong
- The trial is a case series without a comparison group, so results may not prove the mesh is better than standard care. Mesh can also cause complications like infection or seroma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCISIONAL HERNIA/PREVENTION AND CONTROL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Policlinico Tor Vergata
Rome, Lazio, 00133, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.